Infinite 2026: Unlocking new value in existing therapies | McDermott Skip to main content

Infinite 2026: Unlocking new value in existing therapies

Overview


DeepLife hosts this transformative event, exploring how AI is revealing the hidden potential of existing drugs and creating unprecedented opportunities for maximizing value in today’s competitive pharmaceutical landscape.

Emmanuelle Trombe will join a panel of industry leaders, investors, clinicians, patient advocates and researchers to speak on the exploration of new markets, undiscovered targets and innovative approaches to drug lifecycle management.

To learn more and register, please click here.

Dig Deeper

London / In-person / September 24, 2026

HPE Europe 2026

Brussels, Belgium / Speaking Engagements / May 21, 2026

EU Pharmaceutical Law Forum 2026

Nashville, TN / In-person / May 20 - 21, 2026

McDermott HealthEx 2026

Chicago, IL / Speaking Engagements / April 30 – May 1, 2026

17th Annual Advanced Forum on Managed Care Disputes and Litigation

San Francisco, CA / In-person / April 30, 2026

Health Tech Investment Forum 2026

Las Vegas, NV / Speaking Engagements / April 26 – April 30, 2026

Asembia’s AXS26 Summit

Get In Touch